level-one heading

Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 50 /hr
Hire Dr. Dikshat G.
United States
USD 50 /hr

Hematologist-Oncologist & Translational Researcher | Expert in Ph-like ALL & Precision Oncology Award Winning Scientist

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing, Copywriting, General Proofreading & Editing
Research Market Research, User Research, Meta-Research, Gap Analysis, Scientific and Technical Research, Systematic Literature Review
Consulting Healthcare Consulting, Scientific and Technical Consulting
Data & AI Statistical Analysis, Algorithm Design-Non ML, Algorithm Design-ML, Data Cleaning, Data Processing
Product Development Product Validation, Prototyping
Work Experience

Postdoctoral Research fellow

Northwestern University

March 2022 - Present

Post Doctoral Associate

Northwestern University Feinberg School of Medicine

March 2022 - Present

Education

PhD (Hemato-Oncology) (Hematology)

Post Graduate Institute of Medical Education and Research

June 2016 - June 2021

M.Sc (Human Genomics) (Human Genomics )

Panjab University

June 2012 - May 2014

B.Sc (Hons) Microbiology (Biomedical )

Lovely Professional University

June 2009 - May 2012

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
William Yang, Qianyu Guo, Songhua Quan, Zachary R. Chalmers, J. Brandon Parker, Mihai Truica, Mary F. Dufficy, Megan M. Kerber, Karthik Vasan, Dikshat G. Gupta, et al. (2025). Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitors . Science Advances.
Debabrata Chakravarti, James Brandon Parker, Mihai Ioan Truica, William Yang, Zachary R Chalmers, Sarki A. Abdulkadir, Gary E. Schiltz, Songhua Quan, Adam Wei Tsun Steffeck, Navdeep S Chandel, et al. (2025). Impaired Mitochondrial Metabolism is a Critical Cancer Vulnerability for MYC inhibitors . Science Advances.
Anita Giri, Praveen Sharma, Dikshat Gopal Gupta, Minakshi Gupta, Pulkit Rastogi, Srinivasan Peyam, Aashima Arora, Alka Rani Khadwal, Elena Sukacheva, Prashant Sharma, et al. (2025). Evaluating Unghosted Cells (UGC): An Automated Blood Cell Counter‐Derived Novel Red Cell Research Parameter for Its Clinical Utility and Diagnostic Implications Across a Spectrum of Pathological Conditions . International Journal of Laboratory Hematology.
Dikshat Gopal Gupta, Monika, Neelam Varma (2025). Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings . Molecular Diagnosis & Therapy.
Anveshika Soni, Sujay Rainchwar, Reema Singh, Dikshat Gopal Gupta, Nakul Tikare, Rohan Halder, Roy J. Palatty, Vipul Sharad Sheth, Narendra Agrawal, Dinesh Bhurani, et al. (2025). Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience . Clinical Lymphoma Myeloma and Leukemia.
Soni, A., Rainchwar, S., Singh, R., Gupta, D.G., Tikare, N., Halder, R., Palatty, R.J., Sheth, V.S., Agrawal, N., Bhurani, D., et al.(2025). Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience . Clinical Lymphoma, Myeloma and Leukemia. 25. (2). p. e110-e119.
Praveen Sharma, Parveen Bose, Nabhajit Mallik, Dikshat Gopal Gupta, Suneel Rachagiri, Arun Kumar, Jasbir Kaur, Pankaj Malhotra, Neelam Varma, Man Updesh Singh Sachdeva (2024). FLAER as a standalone reagent for paroxysmal nocturnal hemoglobinuria: Do we need to reconsider the guidelines for testing? . International Journal of Laboratory Hematology.
Dikshat Gopal Gupta, Neelam Varma, Sarki Abba Abdulkadir, Sreejesh Sreedharanunni, Man Updesh Singh Sachdeva, Shano Naseem, Parveen Bose, Jogeshwar Binota, Pankaj Malhotra, Alka Khadwal, et al. (2024). A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemia . Cancer.
Sharma, P., Bose, P., Mallik, N., Gupta, D.G., Rachagiri, S., Kumar, A., Kaur, J., Malhotra, P., Varma, N., Sachdeva, M.U.S.(2024). FLAER as a standalone reagent for paroxysmal nocturnal hemoglobinuria: Do we need to reconsider the guidelines for testing? . International Journal of Laboratory Hematology. 46. (2). p. 383-389.
Gupta, M., Kumar, S., Dwivedi, V., Gupta, D.G., Ali, D., Alarifi, S., Patel, A., Yadav, V.K.(2024). Selective synergistic effects of oxalic acid and salicylic acid in enhancing amino acid levels and alleviating lead stress in Zea mays L . Plant Signaling and Behavior. 19. (1).
Gupta, D.G., Varma, N., Abdulkadir, S.A., Sreedharanunni, S., Sachdeva, M.U.S., Naseem, S., Bose, P., Binota, J., Malhotra, P., Khadwal, A., et al.(2024). A surrogate molecular approach for the detection of Philadelphia chromosome–like B-acute lymphoblastic leukemia . Cancer. 130. (5). p. 713-726.
Dikshat Gopal Gupta, Neelam Varma, Praveen Sharma, Mihai I. Truica, Sarki A. Abdulkadir, Parmod Singh, Man Updesh Singh Sachdeva, Shano Naseem, Mohammad Rizwan Siddiqui, Parveen Bose, et al. (2023). Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B‐lineage acute lymphoblastic leukemia: A report of 1021 patients from India . Cancer.
Dikshat Gopal Gupta, Neelam Varma, Mihai Truica, Parmod Singh Tanwar, Sarki Abba Abdulkadir, Mohammad Rizwan Siddiqui, Man Updesh Singh Sachdeva, Shano Naseem, Parveen Bose, Jogeshwar Binota, et al.(2023). POSTER: ALL-205 Deconvoluting & Characterizing the Newly Incorporated Genetic Subtypes & Treatment Outcomes of Acute Lymphoblastic Leukemia: A Report of 1,021 Indian Patients 5-Year Study . Clinical Lymphoma Myeloma and Leukemia. 23. p. S150. Elsevier {BV}
Dikshat Gopal Gupta, Neelam Varma, Sreejesh Sreedharanunni, Sarki Abba Abdulkadir, Shano Naseem, Man Updesh Singh Sachdeva, Jogeshwar Binota, Parveen Bose, Pankaj Malhotra, Alka Khadwal, et al. (2023). ‘Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting . British Journal of Cancer.
Gupta DG, Varma N, Abdulkadir SA, Singh P, Sachdeva MUS, Naseem S, Siddiqui MR, Bose P, Binota J, Malhotra P, et al. (2023). Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia . Clinical and experimental medicine.
Arwood ML, Liu Y, Harkins SK, Weinstock DM, Yang L, Stevenson KE, Plana OD, Dong J, Cirka H, Jones KL, et al. (2023). New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation . Cell chemical biology.
Dikshat Gopal Gupta, Neelam Varma, Ashish Kumar, Shano Naseem, Man Updesh Singh Sachdeva, Sreejesh Sreedharanunni, Jogeshwar Binota, Parveen Bose, Alka Khadwal, Pankaj Malhotra, et al. (2023). Genomic and proteomic characterization of Philadelphia‐like B‐lineage acute lymphoblastic leukemia: A report of Indian patients . Cancer.
Arwood, M.L., Liu, Y., Harkins, S.K., Weinstock, D.M., Yang, L., Stevenson, K.E., Plana, O.D., Dong, J., Cirka, H., Jones, K.L., et al.(2023). New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation . Cell Chemical Biology. 30. (6). p. 618-631.e12.
Gupta, D.G., Varma, N., Kumar, A., Naseem, S., Sachdeva, M.U.S., Sreedharanunni, S., Binota, J., Bose, P., Khadwal, A., Malhotra, P., et al.(2023). Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients . Cancer. 129. (8). p. 1217-1226.
Gupta, D.G., Varma, N., Sharma, P., Truica, M.I., Abdulkadir, S.A., Singh, P., Singh Sachdeva, M.U., Naseem, S., Siddiqui, M.R., Bose, P., et al.(2023). Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from India . Cancer. 129. (21). p. 3390-3404.
Gupta, D.G., Varma, N., Sreedharanunni, S., Abdulkadir, S.A., Naseem, S., Sachdeva, M.U.S., Binota, J., Bose, P., Malhotra, P., Khadwal, A., et al.(2023). ‘Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting . British Journal of Cancer. 129. (1). p. 143-152.
Gupta, D.G., Varma, N., Abdulkadir, S.A., Singh, P., Sachdeva, M.U.S., Naseem, S., Siddiqui, M.R., Bose, P., Binota, J., Malhotra, P., et al.(2023). Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia . Clinical and Experimental Medicine. 23. (8). p. 4539-4551.
Gupta, D.G., Varma, N., Kumar, A., Naseem, S., Sachdeva, M.U.S., Sreedharanunni, S., Binota, J., Bose, P., Gupta, M., Sonam, P., et al.(2022). ALL-061 Delineating the Genomic and Proteomic Landscape of BCR-ABL1-like Acute Lymphoblastic Leukemia Subtype: Bench-to-Bedside Translational Research . Clinical Lymphoma, Myeloma and Leukemia. 22. p. S191-S192.
Gupta, D.G., Varma, N., Kumar, A., Naseem, S., Sachdeva, M.U.S., Binota, J., Bose, P., Gupta, M., Sonam, P., Rana, P., et al.(2022). PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients . Leukemia and Lymphoma. 63. (3). p. 633-643.
Dikshat Gopal Gupta and Neelam Varma and Ashish Kumar and Shano Naseem and Man Updesh Singh Sachdeva and Jogeshwar Binota and Parveen Bose and Minakshi Gupta and Preeti Sonam and Palak Rana and Pankaj Malhotra and Alka Khadwal and Amita Trehan and Subhash Varma(2021). PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients . Leukemia & Lymphoma. p. 1--11. Informa {UK} Limited
Dikshat Gopal Gupta, Neelam Varma, Shano Naseem, Man Updesh Singh Sachdeva, Parveen Bose, Jogeshwar Binota, Ashish Kumar, Minakshi Gupta, Palak Rana, Preeti Sonam, et al.(2021). Characterization of the immunophenotypic aberrancies with respect to common fusion transcripts in B-cell precursor acute lymphoblastic leukaemia - a report of 986 Indian patients . Turkish Journal of Hematology. Galenos Yayinevi
Dikshat Gopal Gupta, Neelam Varma, Ashish Kumar, Shano Naseem, Man Updesh Singh Sachdeva, Jogeshwar Binota, Parveen Bose, Minakshi Gupta, Preeti Sonam, Palak Rana, et al.(2021). ALL-125: PHi-RACE: PGIMER In-House Rapid and Cost-Effective Classifier for the Rapid Detection of BCR-ABLI-Like Acute Lymphoblastic Leukemia in Indian Patients . Clinical Lymphoma Myeloma and Leukemia. 21. p. S268--S269. Elsevier {BV}
Dikshat Gopal Gupta, Neelam Varma, Shano Naseem, Man Updesh Singh Sachdeva, Pankaj Malhotra, Sreejesh Sreedharanunni, Subhash Varma, Parveen Bose, Minakshi Gupta, Palak Rana, et al.(2020). "Detection of BCR-ABL1-like Subtype in Adult Acute Lymphoblastic Leukemia Using Digital Ncounter Nanostring Technology" . Blood. 136. (Supplement 1). p. 13--14. American Society of Hematology